Source: dvm 360

The FDA has approved Pradofloxacin injection for treating respiratory diseases in cattle and swine. Pradofloxacin, a fluoroquinolone-class antimicrobial, is available by prescription from licensed veterinarians as a single injection. For cattle, it’s approved for bovine respiratory disease (BRD) caused by specific pathogens in cattle under one years of age, excluding certain categories. In swine, it’s approved for swine respiratory disease (SRD) in weaned swine intended for slaughter, excluding breeding or nursing piglets.

Each mL contains 200 mg of Pradofloxacin, administered subcutaneously in cattle and intramuscularly in swine. FDA emphasizes antimicrobial stewardship, requiring Veterinary authorization for use. Pradofloxacin is a critically important antimicrobial, with labeling emphasizing its use only after considering nonfluoroquinolone options. The FDA reviewed safety data from multi-site field studies, ensuring safety for both treated animals and edible products.

Read the full story HERE: